Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis

Overview of attention for article published in Multiple Sclerosis Journal, February 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)

Mentioned by

blogs: 1 blog

twitter: 5 X users

Readers on

mendeley: 52 Mendeley

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 7,333 followers.

https://t.co/O2IWEa6J43 ibudilastでニューロフィラメントLは減らないらしい。いいのか悪いのか不明。

Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive #multiplesclerosis https://t.co/3PbOpQiLxy

Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis. https://t.co/9GfRvtvnj3 https://t.co/kuLvXJ3dYC

New secondary paper from #NeuroNEXT NN102 (SPRINT-MS) trial. https://t.co/KTVF0SEh9M

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.